| Dr Joshua Pearlman, MD | |
|
270 Park Ave, Huntington, NY 11743-2787 | |
| (631) 351-2785 | |
| Not Available |
| Full Name | Dr Joshua Pearlman |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 22 Years |
| Location | 270 Park Ave, Huntington, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124098751 | NPI | - | NPPES |
| 02755833 | Medicaid | NY | |
| CB1521 | Other | NY | RAILROAD MEDICARE GROUP |
| P00337233 | Other | NY | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 238306 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Shore - Lij Anesthesiology, Pc | 1153602453 | 779 |
| Office Based Anesthesia Llc | 2163400375 | 29 |
News Archive
Korean researchers have described a novel control system to regulate the expression of a therapeutic transgene by targeting the passenger strand of a microRNA (miR-122) linked to the transgene.
Compressus, a transformational leader in interoperability and workflow solutions for the rapidly growing healthcare IT market, today announced the integration of M*Modal's Speech Understanding technology with the MEDxConnect suite of healthcare interoperability and workflow solutions from Compressus.
Scientists at New York University School of Medicine report in a new study that they have identified the molecular switch that turns on the production of myelin, the fatty insulation around nerve cells that ensures swift and efficient communication in the nervous system.
Micromet, Inc. announced today the pricing of an underwritten public offering of 10 million shares of common stock at a public offering price of $7.00 per share. The Company has granted the underwriters a 30-day option to purchase an additional 1.5 million shares of common stock from the Company. All of the shares in the offering are being sold by Micromet. The closing of the offering is expected to take place on March 17, 2010, subject to the satisfaction of customary closing conditions.
› Verified 7 days ago
| Entity Name | Downtown Bronx Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689618407 PECOS PAC ID: 9638082746 Enrollment ID: O20031106000016 |
News Archive
Korean researchers have described a novel control system to regulate the expression of a therapeutic transgene by targeting the passenger strand of a microRNA (miR-122) linked to the transgene.
Compressus, a transformational leader in interoperability and workflow solutions for the rapidly growing healthcare IT market, today announced the integration of M*Modal's Speech Understanding technology with the MEDxConnect suite of healthcare interoperability and workflow solutions from Compressus.
Scientists at New York University School of Medicine report in a new study that they have identified the molecular switch that turns on the production of myelin, the fatty insulation around nerve cells that ensures swift and efficient communication in the nervous system.
Micromet, Inc. announced today the pricing of an underwritten public offering of 10 million shares of common stock at a public offering price of $7.00 per share. The Company has granted the underwriters a 30-day option to purchase an additional 1.5 million shares of common stock from the Company. All of the shares in the offering are being sold by Micromet. The closing of the offering is expected to take place on March 17, 2010, subject to the satisfaction of customary closing conditions.
› Verified 7 days ago
| Entity Name | North American Partners In Anesthesia Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649264706 PECOS PAC ID: 7719885771 Enrollment ID: O20040108000176 |
News Archive
Korean researchers have described a novel control system to regulate the expression of a therapeutic transgene by targeting the passenger strand of a microRNA (miR-122) linked to the transgene.
Compressus, a transformational leader in interoperability and workflow solutions for the rapidly growing healthcare IT market, today announced the integration of M*Modal's Speech Understanding technology with the MEDxConnect suite of healthcare interoperability and workflow solutions from Compressus.
Scientists at New York University School of Medicine report in a new study that they have identified the molecular switch that turns on the production of myelin, the fatty insulation around nerve cells that ensures swift and efficient communication in the nervous system.
Micromet, Inc. announced today the pricing of an underwritten public offering of 10 million shares of common stock at a public offering price of $7.00 per share. The Company has granted the underwriters a 30-day option to purchase an additional 1.5 million shares of common stock from the Company. All of the shares in the offering are being sold by Micromet. The closing of the offering is expected to take place on March 17, 2010, subject to the satisfaction of customary closing conditions.
› Verified 7 days ago
| Entity Name | Suffolk Anesthesiology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194826420 PECOS PAC ID: 6204725740 Enrollment ID: O20040312000960 |
News Archive
Korean researchers have described a novel control system to regulate the expression of a therapeutic transgene by targeting the passenger strand of a microRNA (miR-122) linked to the transgene.
Compressus, a transformational leader in interoperability and workflow solutions for the rapidly growing healthcare IT market, today announced the integration of M*Modal's Speech Understanding technology with the MEDxConnect suite of healthcare interoperability and workflow solutions from Compressus.
Scientists at New York University School of Medicine report in a new study that they have identified the molecular switch that turns on the production of myelin, the fatty insulation around nerve cells that ensures swift and efficient communication in the nervous system.
Micromet, Inc. announced today the pricing of an underwritten public offering of 10 million shares of common stock at a public offering price of $7.00 per share. The Company has granted the underwriters a 30-day option to purchase an additional 1.5 million shares of common stock from the Company. All of the shares in the offering are being sold by Micromet. The closing of the offering is expected to take place on March 17, 2010, subject to the satisfaction of customary closing conditions.
› Verified 7 days ago
| Entity Name | Metropolitan Lithotriptor Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891027967 PECOS PAC ID: 5193615730 Enrollment ID: O20040317001512 |
News Archive
Korean researchers have described a novel control system to regulate the expression of a therapeutic transgene by targeting the passenger strand of a microRNA (miR-122) linked to the transgene.
Compressus, a transformational leader in interoperability and workflow solutions for the rapidly growing healthcare IT market, today announced the integration of M*Modal's Speech Understanding technology with the MEDxConnect suite of healthcare interoperability and workflow solutions from Compressus.
Scientists at New York University School of Medicine report in a new study that they have identified the molecular switch that turns on the production of myelin, the fatty insulation around nerve cells that ensures swift and efficient communication in the nervous system.
Micromet, Inc. announced today the pricing of an underwritten public offering of 10 million shares of common stock at a public offering price of $7.00 per share. The Company has granted the underwriters a 30-day option to purchase an additional 1.5 million shares of common stock from the Company. All of the shares in the offering are being sold by Micromet. The closing of the offering is expected to take place on March 17, 2010, subject to the satisfaction of customary closing conditions.
› Verified 7 days ago
| Entity Name | Office Based Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407947617 PECOS PAC ID: 2163400375 Enrollment ID: O20040713000424 |
News Archive
Korean researchers have described a novel control system to regulate the expression of a therapeutic transgene by targeting the passenger strand of a microRNA (miR-122) linked to the transgene.
Compressus, a transformational leader in interoperability and workflow solutions for the rapidly growing healthcare IT market, today announced the integration of M*Modal's Speech Understanding technology with the MEDxConnect suite of healthcare interoperability and workflow solutions from Compressus.
Scientists at New York University School of Medicine report in a new study that they have identified the molecular switch that turns on the production of myelin, the fatty insulation around nerve cells that ensures swift and efficient communication in the nervous system.
Micromet, Inc. announced today the pricing of an underwritten public offering of 10 million shares of common stock at a public offering price of $7.00 per share. The Company has granted the underwriters a 30-day option to purchase an additional 1.5 million shares of common stock from the Company. All of the shares in the offering are being sold by Micromet. The closing of the offering is expected to take place on March 17, 2010, subject to the satisfaction of customary closing conditions.
› Verified 7 days ago
| Entity Name | Hand Surgery Associates Of Li, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083661763 PECOS PAC ID: 1355443953 Enrollment ID: O20070228000671 |
News Archive
Korean researchers have described a novel control system to regulate the expression of a therapeutic transgene by targeting the passenger strand of a microRNA (miR-122) linked to the transgene.
Compressus, a transformational leader in interoperability and workflow solutions for the rapidly growing healthcare IT market, today announced the integration of M*Modal's Speech Understanding technology with the MEDxConnect suite of healthcare interoperability and workflow solutions from Compressus.
Scientists at New York University School of Medicine report in a new study that they have identified the molecular switch that turns on the production of myelin, the fatty insulation around nerve cells that ensures swift and efficient communication in the nervous system.
Micromet, Inc. announced today the pricing of an underwritten public offering of 10 million shares of common stock at a public offering price of $7.00 per share. The Company has granted the underwriters a 30-day option to purchase an additional 1.5 million shares of common stock from the Company. All of the shares in the offering are being sold by Micromet. The closing of the offering is expected to take place on March 17, 2010, subject to the satisfaction of customary closing conditions.
› Verified 7 days ago
| Entity Name | Westchester Medical Center Advanced Physician Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912131392 PECOS PAC ID: 3173660776 Enrollment ID: O20091031000042 |
News Archive
Korean researchers have described a novel control system to regulate the expression of a therapeutic transgene by targeting the passenger strand of a microRNA (miR-122) linked to the transgene.
Compressus, a transformational leader in interoperability and workflow solutions for the rapidly growing healthcare IT market, today announced the integration of M*Modal's Speech Understanding technology with the MEDxConnect suite of healthcare interoperability and workflow solutions from Compressus.
Scientists at New York University School of Medicine report in a new study that they have identified the molecular switch that turns on the production of myelin, the fatty insulation around nerve cells that ensures swift and efficient communication in the nervous system.
Micromet, Inc. announced today the pricing of an underwritten public offering of 10 million shares of common stock at a public offering price of $7.00 per share. The Company has granted the underwriters a 30-day option to purchase an additional 1.5 million shares of common stock from the Company. All of the shares in the offering are being sold by Micromet. The closing of the offering is expected to take place on March 17, 2010, subject to the satisfaction of customary closing conditions.
› Verified 7 days ago
| Entity Name | Long Island Digestive Endoscopy Center Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1235551052 PECOS PAC ID: 3971728221 Enrollment ID: O20140701000364 |
News Archive
Korean researchers have described a novel control system to regulate the expression of a therapeutic transgene by targeting the passenger strand of a microRNA (miR-122) linked to the transgene.
Compressus, a transformational leader in interoperability and workflow solutions for the rapidly growing healthcare IT market, today announced the integration of M*Modal's Speech Understanding technology with the MEDxConnect suite of healthcare interoperability and workflow solutions from Compressus.
Scientists at New York University School of Medicine report in a new study that they have identified the molecular switch that turns on the production of myelin, the fatty insulation around nerve cells that ensures swift and efficient communication in the nervous system.
Micromet, Inc. announced today the pricing of an underwritten public offering of 10 million shares of common stock at a public offering price of $7.00 per share. The Company has granted the underwriters a 30-day option to purchase an additional 1.5 million shares of common stock from the Company. All of the shares in the offering are being sold by Micromet. The closing of the offering is expected to take place on March 17, 2010, subject to the satisfaction of customary closing conditions.
› Verified 7 days ago
| Entity Name | Great South Bay Endoscopy Center Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1366864514 PECOS PAC ID: 5991921264 Enrollment ID: O20140722001384 |
News Archive
Korean researchers have described a novel control system to regulate the expression of a therapeutic transgene by targeting the passenger strand of a microRNA (miR-122) linked to the transgene.
Compressus, a transformational leader in interoperability and workflow solutions for the rapidly growing healthcare IT market, today announced the integration of M*Modal's Speech Understanding technology with the MEDxConnect suite of healthcare interoperability and workflow solutions from Compressus.
Scientists at New York University School of Medicine report in a new study that they have identified the molecular switch that turns on the production of myelin, the fatty insulation around nerve cells that ensures swift and efficient communication in the nervous system.
Micromet, Inc. announced today the pricing of an underwritten public offering of 10 million shares of common stock at a public offering price of $7.00 per share. The Company has granted the underwriters a 30-day option to purchase an additional 1.5 million shares of common stock from the Company. All of the shares in the offering are being sold by Micromet. The closing of the offering is expected to take place on March 17, 2010, subject to the satisfaction of customary closing conditions.
› Verified 7 days ago
| Entity Name | South Island Gastroenterology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043628282 PECOS PAC ID: 6103149976 Enrollment ID: O20141231000662 |
News Archive
Korean researchers have described a novel control system to regulate the expression of a therapeutic transgene by targeting the passenger strand of a microRNA (miR-122) linked to the transgene.
Compressus, a transformational leader in interoperability and workflow solutions for the rapidly growing healthcare IT market, today announced the integration of M*Modal's Speech Understanding technology with the MEDxConnect suite of healthcare interoperability and workflow solutions from Compressus.
Scientists at New York University School of Medicine report in a new study that they have identified the molecular switch that turns on the production of myelin, the fatty insulation around nerve cells that ensures swift and efficient communication in the nervous system.
Micromet, Inc. announced today the pricing of an underwritten public offering of 10 million shares of common stock at a public offering price of $7.00 per share. The Company has granted the underwriters a 30-day option to purchase an additional 1.5 million shares of common stock from the Company. All of the shares in the offering are being sold by Micromet. The closing of the offering is expected to take place on March 17, 2010, subject to the satisfaction of customary closing conditions.
› Verified 7 days ago
| Entity Name | Lighthouse Endoscopy Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437501541 PECOS PAC ID: 3072892975 Enrollment ID: O20161117000438 |
News Archive
Korean researchers have described a novel control system to regulate the expression of a therapeutic transgene by targeting the passenger strand of a microRNA (miR-122) linked to the transgene.
Compressus, a transformational leader in interoperability and workflow solutions for the rapidly growing healthcare IT market, today announced the integration of M*Modal's Speech Understanding technology with the MEDxConnect suite of healthcare interoperability and workflow solutions from Compressus.
Scientists at New York University School of Medicine report in a new study that they have identified the molecular switch that turns on the production of myelin, the fatty insulation around nerve cells that ensures swift and efficient communication in the nervous system.
Micromet, Inc. announced today the pricing of an underwritten public offering of 10 million shares of common stock at a public offering price of $7.00 per share. The Company has granted the underwriters a 30-day option to purchase an additional 1.5 million shares of common stock from the Company. All of the shares in the offering are being sold by Micromet. The closing of the offering is expected to take place on March 17, 2010, subject to the satisfaction of customary closing conditions.
› Verified 7 days ago
| Entity Name | North Shore - Lij Anesthesiology, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417401266 PECOS PAC ID: 1153602453 Enrollment ID: O20161228001498 |
News Archive
Korean researchers have described a novel control system to regulate the expression of a therapeutic transgene by targeting the passenger strand of a microRNA (miR-122) linked to the transgene.
Compressus, a transformational leader in interoperability and workflow solutions for the rapidly growing healthcare IT market, today announced the integration of M*Modal's Speech Understanding technology with the MEDxConnect suite of healthcare interoperability and workflow solutions from Compressus.
Scientists at New York University School of Medicine report in a new study that they have identified the molecular switch that turns on the production of myelin, the fatty insulation around nerve cells that ensures swift and efficient communication in the nervous system.
Micromet, Inc. announced today the pricing of an underwritten public offering of 10 million shares of common stock at a public offering price of $7.00 per share. The Company has granted the underwriters a 30-day option to purchase an additional 1.5 million shares of common stock from the Company. All of the shares in the offering are being sold by Micromet. The closing of the offering is expected to take place on March 17, 2010, subject to the satisfaction of customary closing conditions.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joshua Pearlman, MD 68 S Service Rd, Suite 350q, Melville, NY 11747-2354 Ph: (516) 945-3000 | Dr Joshua Pearlman, MD 270 Park Ave, Huntington, NY 11743-2787 Ph: (631) 351-2785 |
News Archive
Korean researchers have described a novel control system to regulate the expression of a therapeutic transgene by targeting the passenger strand of a microRNA (miR-122) linked to the transgene.
Compressus, a transformational leader in interoperability and workflow solutions for the rapidly growing healthcare IT market, today announced the integration of M*Modal's Speech Understanding technology with the MEDxConnect suite of healthcare interoperability and workflow solutions from Compressus.
Scientists at New York University School of Medicine report in a new study that they have identified the molecular switch that turns on the production of myelin, the fatty insulation around nerve cells that ensures swift and efficient communication in the nervous system.
Micromet, Inc. announced today the pricing of an underwritten public offering of 10 million shares of common stock at a public offering price of $7.00 per share. The Company has granted the underwriters a 30-day option to purchase an additional 1.5 million shares of common stock from the Company. All of the shares in the offering are being sold by Micromet. The closing of the offering is expected to take place on March 17, 2010, subject to the satisfaction of customary closing conditions.
› Verified 7 days ago
Dr. Leonard Giambalvo, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 270 Park Ave, Huntington, NY 11743 Phone: 631-351-2785 | |
Dr. Howard Frank, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 195 E Main St, Huntington, NY 11743 Phone: 631-385-8677 | |
Joshua Sisser, M.D. Anesthesiology Medicare: May Accept Medicare Assignments Practice Location: 270 Park Ave, Huntington, NY 11743 Phone: 631-351-2785 | |
Dr. Janet Grotticelli, D.O. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 14 Crest Rd, Huntington, NY 11743 Phone: 201-805-4464 Fax: 201-760-0195 | |
Dr. David Soohoo, Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: Department Of Anesthesiology, 270 Park Ave, Huntington, NY 11743 Phone: 631-351-2000 | |
Dr. Alexander Charles Hogg, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 270 Park Avenue, Department Of Anesthesiology, Huntington, NY 11743 Phone: 631-351-2000 Fax: 202-877-3699 |